These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 29175080

  • 1. Targeted iron nanoparticles with platinum-(IV) prodrugs and anti-EZH2 siRNA show great synergy in combating drug resistance in vitro and in vivo.
    Yu C, Ding B, Zhang X, Deng X, Deng K, Cheng Z, Xing B, Jin D, Ma P, Lin J.
    Biomaterials; 2018 Feb; 155():112-123. PubMed ID: 29175080
    [Abstract] [Full Text] [Related]

  • 2. Fabricating nanoparticles co-loaded with survivin siRNA and Pt(IV) prodrug for the treatment of platinum-resistant lung cancer.
    Ma S, Li X, Ran M, Ji M, Gou J, Yin T, He H, Wang Y, Zhang Y, Tang X.
    Int J Pharm; 2021 May 15; 601():120577. PubMed ID: 33839227
    [Abstract] [Full Text] [Related]

  • 3. Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin.
    Shi H, Cheng Q, Yuan S, Ding X, Liu Y.
    Chemistry; 2015 Nov 09; 21(46):16547-54. PubMed ID: 26405808
    [Abstract] [Full Text] [Related]

  • 4. Platinum(iv) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance.
    Chen Q, Yang Y, Lin X, Ma W, Chen G, Li W, Wang X, Yu Z.
    Chem Commun (Camb); 2018 May 22; 54(42):5369-5372. PubMed ID: 29744485
    [Abstract] [Full Text] [Related]

  • 5. Engineering liposomal nanoparticles of cholesterol-tethered amphiphilic Pt(iv) prodrugs with prolonged circulation time in blood.
    Datta P, Bang S, Yue Z, Beach T, Stilgenbauer M, Wang H, Bowers DJ, Kurokawa M, Xiao H, Zheng YR.
    Dalton Trans; 2020 Jun 23; 49(24):8107-8113. PubMed ID: 32490446
    [Abstract] [Full Text] [Related]

  • 6. An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects.
    Hernández-Gil J, Cobaleda-Siles M, Zabaleta A, Salassa L, Calvo J, Mareque-Rivas JC.
    Adv Healthc Mater; 2015 May 23; 4(7):1034-42. PubMed ID: 25846677
    [Abstract] [Full Text] [Related]

  • 7. Enhancer of zeste homolog 2 promotes cisplatin resistance by reducing cellular platinum accumulation.
    Sun S, Zhao S, Yang Q, Wang W, Cai E, Wen Y, Yu L, Wang Z, Cai J.
    Cancer Sci; 2018 Jun 23; 109(6):1853-1864. PubMed ID: 29630768
    [Abstract] [Full Text] [Related]

  • 8. Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: an in-vitro study.
    Ratzon E, Najajreh Y, Salem R, Khamaisie H, Ruthardt M, Mahajna J.
    BMC Cancer; 2016 Feb 23; 16():140. PubMed ID: 26906901
    [Abstract] [Full Text] [Related]

  • 9. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.
    Garmann D, Warnecke A, Kalayda GV, Kratz F, Jaehde U.
    J Control Release; 2008 Oct 21; 131(2):100-6. PubMed ID: 18691617
    [Abstract] [Full Text] [Related]

  • 10. Near-infrared light-mediated photoactivation of a platinum antitumor prodrug and simultaneous cellular apoptosis imaging by upconversion-luminescent nanoparticles.
    Min Y, Li J, Liu F, Yeow EK, Xing B.
    Angew Chem Int Ed Engl; 2014 Jan 20; 53(4):1012-6. PubMed ID: 24311528
    [Abstract] [Full Text] [Related]

  • 11. An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance.
    Ai F, Sun T, Xu Z, Wang Z, Kong W, To MW, Wang F, Zhu G.
    Dalton Trans; 2016 Aug 16; 45(33):13052-60. PubMed ID: 27430044
    [Abstract] [Full Text] [Related]

  • 12. Self-assembled Lipid Nanoparticles for Ratiometric Codelivery of Cisplatin and siRNA Targeting XPF to Combat Drug Resistance in Lung Cancer.
    Li C, Li T, Huang L, Yang M, Zhu G.
    Chem Asian J; 2019 May 02; 14(9):1570-1576. PubMed ID: 30843348
    [Abstract] [Full Text] [Related]

  • 13. Precisely Assembled Nanoparticles against Cisplatin Resistance via Cancer-Specific Targeting of Mitochondria and Imaging-Guided Chemo-Photothermal Therapy.
    Yang GG, Pan ZY, Zhang DY, Cao Q, Ji LN, Mao ZW.
    ACS Appl Mater Interfaces; 2020 Sep 30; 12(39):43444-43455. PubMed ID: 32883070
    [Abstract] [Full Text] [Related]

  • 14. Functionalized nonporous silica nanoparticles as carriers for Pt(iv) anticancer prodrugs.
    Ravera M, Gabano E, Zanellato I, Perin E, Arrais A, Osella D.
    Dalton Trans; 2016 Nov 01; 45(43):17233-17240. PubMed ID: 27722707
    [Abstract] [Full Text] [Related]

  • 15. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.
    Savino S, Marzano C, Gandin V, Hoeschele JD, Natile G, Margiotta N.
    Int J Mol Sci; 2018 Jul 14; 19(7):. PubMed ID: 30011897
    [Abstract] [Full Text] [Related]

  • 16. Efficient co-delivery of a Pt(IV) prodrug and a p53 activator to enhance the anticancer activity of cisplatin.
    Ma R, Wang Y, Yan L, Ma L, Wang Z, Chan HC, Chiu SK, Chen X, Zhu G.
    Chem Commun (Camb); 2015 May 07; 51(37):7859-62. PubMed ID: 25854514
    [Abstract] [Full Text] [Related]

  • 17. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.
    Tan MX, Wang ZF, Qin QP, Zou BQ, Liang H.
    Dalton Trans; 2020 Feb 07; 49(5):1613-1619. PubMed ID: 31942585
    [Abstract] [Full Text] [Related]

  • 18. Emerging platinum(iv) prodrugs to combat cisplatin resistance: from isolated cancer cells to tumor microenvironment.
    Wang Z, Deng Z, Zhu G.
    Dalton Trans; 2019 Feb 19; 48(8):2536-2544. PubMed ID: 30633263
    [Abstract] [Full Text] [Related]

  • 19. Imidazole modified Pt(iv) prodrug-loaded multi-stage pH responsive nanoparticles to overcome cisplatin resistance.
    Kang X, Wang Y, Chen Z, Wu Y, Chen H, Yang X, Yu C.
    Chem Commun (Camb); 2020 Sep 28; 56(76):11271-11274. PubMed ID: 32830841
    [Abstract] [Full Text] [Related]

  • 20. Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts.
    Zhao Y, Woods JA, Farrer NJ, Robinson KS, Pracharova J, Kasparkova J, Novakova O, Li H, Salassa L, Pizarro AM, Clarkson GJ, Song L, Brabec V, Sadler PJ.
    Chemistry; 2013 Jul 15; 19(29):9578-91. PubMed ID: 23733242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.